
1. gastroenterology. 1996 nov;111(5):1307-12.

long-term efficacy ribavirin plus interferon alfa treatment chronic 
hepatitis c.

lai my(1), kao jh, yang pm, wang jt, chen pj, chan kw, chu js, chen ds.

author information: 
(1)graduate institute clinical medicine, national taiwan university college of
medicine hospital, taipei.

background & aims: sustained response interferon treatment chronic
hepatitis c unsatisfactory. study examined whether combining interferon
alfa ribavirin induces better sustained efficacy interferon alone 
the treatment chronic hepatitis c.
methods: sixty noncirrhotic patients chronic hepatitis c randomly
assigned three groups. group 1 received 1200 mg oral ribavirin daily plus 3
million units recombinant interferon alfa 2a thrice weekly 24 weeks, group
2 received dose interferon alfa 2a alone 24 weeks, group 3
received treatment. patients followed additional 96
weeks.
results: end treatment, complete response (normal serum alanine
aminotransferase level undetectable serum hepatitis c virus rna) achieved
in 16 21 patients group 1 (76%), compared 6 19 group 2
(32%) none group 3. 96 weeks end treatment, patients in
group 1 sustained higher complete response rate patients group 2 (43%
vs. 6%).
conclusions: combined treatment ribavirin interferon alfa 2a 24
weeks effective interferon alfa 2a alone treatment of
chronic hepatitis c. biochemical virological responses sustained 
about one half treated patients least 2 years cessation of
the therapy.

doi: 10.1053/gast.1996.v111.pm8898645 
pmid: 8898645  [indexed medline]

